GB1356094A - Pharmaceutical and veterinary compositions for the treatment of hyperlipoproteinaemia - Google Patents

Pharmaceutical and veterinary compositions for the treatment of hyperlipoproteinaemia

Info

Publication number
GB1356094A
GB1356094A GB5570472A GB5570472A GB1356094A GB 1356094 A GB1356094 A GB 1356094A GB 5570472 A GB5570472 A GB 5570472A GB 5570472 A GB5570472 A GB 5570472A GB 1356094 A GB1356094 A GB 1356094A
Authority
GB
United Kingdom
Prior art keywords
hyperlipoproteinaemia
pharmaceutical
treatment
composition
veterinary compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5570472A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of GB1356094A publication Critical patent/GB1356094A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB5570472A 1971-12-11 1972-12-01 Pharmaceutical and veterinary compositions for the treatment of hyperlipoproteinaemia Expired GB1356094A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2161588A DE2161588C3 (de) 1971-12-11 1971-12-11 Mittel zur Behandlung von Hyperlipoproteinämien

Publications (1)

Publication Number Publication Date
GB1356094A true GB1356094A (en) 1974-06-12

Family

ID=5827712

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5570472A Expired GB1356094A (en) 1971-12-11 1972-12-01 Pharmaceutical and veterinary compositions for the treatment of hyperlipoproteinaemia

Country Status (14)

Country Link
AT (1) AT327373B (de)
AU (1) AU466300B2 (de)
BE (1) BE792421A (de)
BR (1) BR7208624D0 (de)
CA (1) CA989307A (de)
DD (1) DD102583A5 (de)
DE (1) DE2161588C3 (de)
FR (1) FR2162493B1 (de)
GB (1) GB1356094A (de)
HU (1) HU167337B (de)
IL (1) IL40912A (de)
MY (1) MY7700129A (de)
NL (1) NL159579B (de)
ZA (1) ZA728251B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820739A (en) * 1982-06-28 1989-04-11 Lucta, S.A. Fat suppressant

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2502678C3 (de) * 1975-01-23 1981-05-14 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Arzneimittel zur Behandlung primärer und sekundärer Hyperlipoproteinämien
DE2621873C3 (de) 1976-05-17 1981-05-07 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Arzneimittel zur Behandlung von Hypercholesterinämien
FR2430229A1 (fr) * 1978-01-16 1980-02-01 Laruelle Claude Nouvelles compositions pour le traitement des hyperlipoproteinemies et procedes de preparation
US4859703A (en) * 1987-06-15 1989-08-22 Warner-Lambert Company Lipid regulating compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820739A (en) * 1982-06-28 1989-04-11 Lucta, S.A. Fat suppressant

Also Published As

Publication number Publication date
DE2161588A1 (de) 1973-06-20
DE2161588B2 (de) 1976-05-26
HU167337B (de) 1975-09-27
IL40912A0 (en) 1973-01-30
CA989307A (en) 1976-05-18
DD102583A5 (de) 1973-12-20
BR7208624D0 (pt) 1973-09-20
DE2161588C3 (de) 1980-02-14
FR2162493A1 (de) 1973-07-20
AU4991872A (en) 1974-06-13
NL159579B (nl) 1979-03-15
AU466300B2 (en) 1975-10-23
ZA728251B (en) 1973-07-25
FR2162493B1 (de) 1975-06-20
BE792421A (fr) 1973-06-07
IL40912A (en) 1975-11-25
ATA1049172A (de) 1975-04-15
MY7700129A (en) 1977-12-31
AT327373B (de) 1976-01-26
NL7216788A (de) 1973-06-13

Similar Documents

Publication Publication Date Title
ES375013A1 (es) Un procedimiento para la preparacion de un nuevo compuesto pirrolobenzodiazepinona.
GB1495733A (en) Pharmaceutical preparations
GB1356094A (en) Pharmaceutical and veterinary compositions for the treatment of hyperlipoproteinaemia
ES398553A1 (es) Un procedimiento para la preparacion de una composicion de-tergente.
ES437150A1 (es) Procedimiento para la produccion de derivados de xantina.
ES411901A1 (es) Procedimiento para la preparacion de esteres liquidos cris-talinos.
GB1416292A (en) X-ray contrast agents their application and a process for their production
ES405479A1 (es) Un procedimiento para la preparacion de derivados de benzo-diacepina.
ES405555A1 (es) Procedimiento para la preparacion de derivados de ftalazo- na.
ES404860A1 (es) Un procedimiento para preparar derivados n-carboxilicos de los antibioticos cefradina y cefalaxina.
ES401228A1 (es) Procedimiento de obtencion de sales complejas de cisteina yde cinc.
ES384991A1 (es) Procedimiento para el acoplamiento reductivo de compuestos halo - organicos.
FR2240731A1 (de)
ES437058A1 (es) Procedimiento para la preparacion de nuevos derivados de ci-clopentano.
GB1367866A (en) Process for the preparation of tricyclic compounds
ES411737A1 (es) Procedimiento para la preparacion de compuestos heteroci- clicos binucleares.
GB1342232A (en) Aryliminothiazolidines a process for their preparation and their use as acaricides
ES400624A1 (es) Procedimiento para la preparacion de derivados de acido pe-niciloico.
ES374255A1 (es) Un procedimiento para la preparacion de una composicion de-tergente.
GB1065508A (en) 7-(ª‡-orª‰-azido acylamino) cephalosporanic acid and derivatives thereof
ES391036A1 (es) Un procedimiento para la preparacion de derivados n-susti- tuidos de compuestos de 14-hidroxidihidronormorfina.
ES420221A1 (es) Un procedimiento para la preparacion de compuestos deriva- dos de estibazol.
ES438100A1 (es) Procedimiento para la preparacion de nuevos compuestos solu-bles que contienen azufre.
ES409309A1 (es) Un metodo para preparar compuestos de alcanolamina susti- tuida.
ES401700A1 (es) Procedimiento para la preparacion de nuevos compuestos de triglicidilo.

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee